The frequency, preventability, severity, root causes, and projected costs of adverse drug events (ADEs) occurring after or causing admission to a four-hospital integrated academic health network were studied. The sample included all admissions during a 53-day study period. Events were identified through daily record review of a random patient sample, computerized flags, and self-reporting. A case review committee validated the occurrence, classification, and root causes of the events. Additional length of stay and costs associated with ADEs were analyzed by using a case-control, multiple linear regression model. The estimated ADE rate during hospitalization was 4.2 events per 100 admissions, with a cost of $2162 per ADE. In addition, 3.2% of admissions were caused by ADEs, with an associated cost of $6685 per event. Fifteen percent of hospital ADEs and 76% of ADEs causing admission were judged preventable. The annual cost to the organization for events occurring during hospitalization was $1.7 million, and the cost of preventable ADEs was $260,000, while the projected costs of preventable ADEs causing admission were $3.8 million. The rate of admissions to the mental health center caused by ADEs was higher than for other settings at 13.6%, with a cost of preventable ADEs of $1.3 million. Patient noncompliance was judged to be the cause of the 69% of the ADEs causing admission. Seventy-one percent of the serious medication errors occurred at the prescribing stage of the medication-use process. ADEs were frequent, costly, and often preventable and resulted in many admissions to a mental health center.

 

This article has been cited by other articles:

				T. S. Field, P. Rochon, M. Lee, L. Gavendo, S. Subramanian, S. Hoover, J. Baril, and J. Gurwitz Costs Associated with Developing and Implementing a Computerized Clinical Decision Support System for Medication Dosing for Patients with Renal Insufficiency in the Long-term Care Setting J. Am. Med. Inform. Assoc., July 1, 2008; 15(4): 466 - 472. [Abstract] [Full Text] [PDF]

				L. A. Thomsen, A. G Winterstein, B. Sondergaard, L. S. Haugbolle, and A. Melander Systematic Review of the Incidence and Characteristics of Preventable Adverse Drug Events in Ambulatory Care Ann. Pharmacother., September 1, 2007; 41(9): 1411 - 1426. [Abstract] [Full Text] [PDF]

				S. M. Handler, R. L. Altman, S. Perera, J. T. Hanlon, S. A. Studenski, J. E. Bost, M. I. Saul, and D. B. Fridsma A Systematic Review of the Performance Characteristics of Clinical Event Monitor Signals Used to Detect Adverse Drug Events in the Hospital Setting J. Am. Med. Inform. Assoc., July 1, 2007; 14(4): 451 - 458. [Abstract] [Full Text] [PDF]

				S. M. Maviglia, J. Y. Yoo, C. Franz, E. Featherstone, W. Churchill, D. W. Bates, T. K. Gandhi, and E. G. Poon Cost-Benefit Analysis of a Hospital Pharmacy Bar Code Solution Arch Intern Med, April 23, 2007; 167(8): 788 - 794. [Abstract] [Full Text] [PDF]

				S. Kane-Gill, R. S. Rea, M. M. Verrico, and R. J. Weber Adverse-drug-event rates for high-cost and high-use drugs in the intensive care unit. Am. J. Health Syst. Pharm., October 1, 2006; 63(19): 1876 - 1881. [Abstract] [Full Text] [PDF]

				D. M. Tarn, J. Heritage, D. A. Paterniti, R. D. Hays, R. L. Kravitz, and N. S. Wenger Physician communication when prescribing new medications. Arch Intern Med, September 25, 2006; 166(17): 1855 - 1862. [Abstract] [Full Text] [PDF]

				S. T. McIntosh and J. B. Petropoulos Using data from automated dispensing units to identify adverse drug reactions Am. J. Health Syst. Pharm., November 15, 2005; 62(22): 2397 - 2400. [Full Text] [PDF]

				L. Osterberg and T. Blaschke Adherence to Medication N. Engl. J. Med., August 4, 2005; 353(5): 487 - 497. [Full Text] [PDF]

				G. K Al-Tajir and W. N Kelly Epidemiology, Comparative Methods of Detection, and Preventability of Adverse Drug Events Ann. Pharmacother., July 1, 2005; 39(7): 1169 - 1174. [Abstract] [Full Text] [PDF]

				T. S. Field, J. H. Gurwitz, L. R. Harrold, J. M. Rothschild, K. Debellis, A. C. Seger, L. S. Fish, L. Garber, M. Kelleher, and D. W. Bates Strategies for Detecting Adverse Drug Events among Older Persons in the Ambulatory Setting J. Am. Med. Inform. Assoc., November 1, 2004; 11(6): 492 - 498. [Abstract] [Full Text] [PDF]

				S. N. Kucukarslan, M. Peters, M. Mlynarek, and D. A. Nafziger Pharmacists on Rounding Teams Reduce Preventable Adverse Drug Events in Hospital General Medicine Units Arch Intern Med, September 22, 2003; 163(17): 2014 - 2018. [Abstract] [Full Text] [PDF]

				D. W. Bates, R. S. Evans, H. Murff, P. D. Stetson, L. Pizziferri, and G. Hripcsak Detecting Adverse Events Using Information Technology J. Am. Med. Inform. Assoc., March 1, 2003; 10(2): 115 - 128. [Abstract] [Full Text] [PDF]